argenx SE | ARGX - Ebit





Ebit Veränderung Datum
AstraZeneca USD 3.16B 3.95B 2026-06
Genmab DKK 407M 221M 2026-06
GlaxoSmithKline GBP 2.6B 312M 2026-06
GRIFOLS EUR 428M 179M 2026-06
Hikma Pharmaceutical USD 348M 31M 2025-12
Lakefront Biotherapeutics EUR -63.7M 844.26M 2026-03
Qiagen NV USD 96.88M 25M 2026-03
UCB EUR 1.29B 571M 2025-12